Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution Experience (Unbekannt)
- Neue Suche nach: Vrontis, Konstantinos
- Neue Suche nach: Economidou, Sofia C.
- Neue Suche nach: Fotopoulos, George
- Neue Suche nach: Vrontis, Konstantinos
- Neue Suche nach: Economidou, Sofia C.
- Neue Suche nach: Fotopoulos, George
In:
Cancer Investigation
;
40
, 2
;
124-131
;
2022
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution Experience
-
Beteiligte:Vrontis, Konstantinos ( Autor:in ) / Economidou, Sofia C. ( Autor:in ) / Fotopoulos, George ( Autor:in )
-
Erschienen in:Cancer Investigation ; 40, 2 ; 124-131
-
Verlag:
- Neue Suche nach: Taylor & Francis
-
Erscheinungsdatum:07.02.2022
-
Format / Umfang:8 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Unbekannt
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 40, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 91
-
Surgical Trauma-induced CCL2 Upregulation Mediates Lung Cancer Progression by Promoting Treg Recruitment in Mice and PatientsZhao, Su / Zheng, Xiaoyu / Zhu, Xidong / Ning, Jinfeng / Zhu, Kaibin / Yan, Yubo / Zhang, Jian / Bu, Jianlong / Liu, Mengfeng / Xu, Shidong et al. | 2022
- 103
-
X-Linked Tumor Suppressor Genes Act as Presumed Contributors in the Sex Chromosome-Autosome Crosstalk in CancersDhabhai, Bhanupriya / Sharma, Amit / Maciaczyk, Jarek / Dakal, Tikam Chand et al. | 2022
- 111
-
Thoughts and Consideration Regarding Immigrant Clinicians: Is Cultural Preservation Influencing Providers’ Practice in HPV Vaccination?Ashing, Kimlin T. / Ragin, Camille / Ariyo, Oluwatosin / Amini, Arya et al. | 2022
- 115
-
Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after One Year of the COVID-19 PandemicJavadinia, Seyed Alireza / Ariamanesh, Mona / Nabavifard, Maryam / Porouhan, Pejman / PeyroShabany, Babak / Fazilat-Panah, Danial / Hatami, Farbod / Ghasemi, Ahmad / Lyman, Gary H. / Welsh, James S. et al. | 2022
- 124
-
Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution ExperienceVrontis, Konstantinos / Economidou, Sofia C. / Fotopoulos, George et al. | 2022
- 132
-
Current Use and Limitations of Cultured High-Grade Meningioma Cells in Neuro-Oncological Research – In Response to: “Caution Using Meningioma Cell Lines as Tumor Models”Martínez Santos, Jaime L. / Suarez-Meade, Paola / Cachia, David / Lindhorst, Scott M. / Das, Arabinda et al. | 2022
- 134
-
Identification of a Novel Pyroptosis-Related Gene Signature for Predicting Prognosis in Bladder CancerFu, Jianhan / Wang, Yinhuai et al. | 2022
- 151
-
Approaches for Head and Neck Cancer Research – Current Status and the Way ForwardV., Barghavi / Femina T., Arokia / Iyengar, DivyaSowrirajan / K., Archana / Ravi, Maddaly et al. | 2022
- 173
-
An Introduction to the Relationship Between Lewis x and Malignancy Mainly Related to Breast Cancer and Head Neck Squamous Cell Carcinoma (HNSCC)Croce, Maria Virginia et al. | 2022
- 184
-
Fooled by Randomness. The Misleading Effect of Treatment Crossover in Randomized Trials of Therapies with Marginal Treatment BenefitValentí, Vicente / Jiménez-Fonseca, Paula / Msaouel, Pavlos / Salazar, Ramón / Carmona-Bayonas, Alberto et al. | 2022
- 189
-
Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint InhibitorsYamamoto, Takafumi / Ito, Takanori / Hase, Tetsunari / Ishigami, Masatoshi / Mizuno, Kazuyuki / Yamamoto, Kenta / Imai, Norihiro / Ishizu, Yoji / Honda, Takashi / Shibata, Hirofumi et al. | 2022
- 199
-
Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) StudyBilici, Ahmet / Uysal, Mukremin / Menekse, Serkan / Akin, Semih / Yildiz, Fatih / Turan, Merve / Sezgin Goksu, Sema / Beypinar, Ismail / Sakalar, Teoman / Değirmenci, Mustafa et al. | 2022